Evaluation of Smartphone Versions of VAS and NRS for Use in Adults

Postoperative Pain Clinical Trial

— Panda  

Official title:

The Evaluation of Smartphone Versions of the Visual Analogue Scale and Numeric Rating Scale as Postoperative Pain Assessment Tools

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04139590
• Other study ID #: H1601196
• Status: Completed
• Phase: N/A
• Start date: July 25, 2016
• Est. completion date: August 26, 2016

Study information

• Verified date: October 2019
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A large number of patients experience significant pain after surgery, and more patients report pain after discharge from hospital than before. This issue has been observed in patients who receive peripheral nerve blocks, the effects of which often wear off after discharge. There are numerous barriers to the effective control of pain away from the direct supervision of medical professionals, and personalized management strategies are necessary in order to overcome these barriers. The first step of adequate pain management is accurate pain assessment. Therefore, this study aims to validate a smartphone-based pain assessment tool that patients can access at home.

Description:

1. Purpose:

The purpose of this study is to establish whether the Panda versions of the 100mm VAS (Visual Analogue Scale) and NRS-11 (Numeric Rating Scale) agree adequately with and can therefore be used in lieu of already validated paper versions of these scales for the evaluation of post-operative pain in adults. The Panda versions of the pain assessment scales have been condensed in size onto an iPod Touch screen but otherwise appear the same as traditional paper versions.

2. Hypothesis:

There are no significant differences in the failure rates in obtaining pain scores and the pain scores obtained using Panda versions of the 100mm VAS and NRS-11 compared to the traditional paper versions.

3. Justification:

The management of acute post-operative pain has a profound impact on a patient's short- and long-term wellbeing. Studies have shown that up to 70-80% of patients experience pain after surgery, with the majority reporting moderate, severe or extreme pain at some point. Ineffective pain management can increase the risk of venous thromboembolism, ischemic heart disease, pneumonia, poor wound healing , insomnia, anxiety and chronic post surgical pain (CPSP). The management of postoperative pain after patients leave hospital is especially inadequate, with more patients reporting pain after discharge than before. Although peripheral nerve blocks (PNB) have demonstrated benefit in reducing immediate/in-hospital postoperative pain compared to general anesthesia (GA), this benefit is not sustained after patients are discharged. In fact, more patients who received PNB report their pain as "severe", "excruciating" or "extreme" and seek medical attention after leaving hospital, than those who were under GA. The nociceptive barrage after the signal blockade by regional anesthesia wears off can theoretically lead to hyperalgesia, and the substantial increase in acute pain over a period of hours can be highly traumatic for patients. In order to minimize this effect, patients are often advised to begin the titration of their oral analgesics prior to the resolution of their nerve blocks, often when they do not feel much pain yet. Potential barriers encountered during this process can include the lack of incentive to begin analgesics in the presence of residual nociceptive blockade, the difficulty of titrating medications away from the direct supervision of medical professionals, and the fear of medication overdose. Therefore, detailed, easily comprehensible and patient specific pain management instructions need to be provided as a part of the discharge plan in order to facilitate patient compliance.

The first step involves developing a practical tool that allows for the accurate and reliable assessment and recording of pain severity that patients can use from home. Pain is defined as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage". It is a highly individual experience. Therefore, self-report is considered the gold standard for pain assessment, with the Verbal Rating Scale (VRS), Visual Analogue Scale (VAS) and Numeric Rating Scale (NRS) being the three most validated self-report scales in adults. The VAS-100mm is a 100mm line with the anchoring words "no pain" and "worst imaginable pain" at the bottom and top, respectively. The NRS-11 is a line marked with numbers from 0 to 10 at even intervals, with the anchoring words "no pain" and "worst pain imaginable" at 0 and 10, respectively. Digital versions of pain scales that can be downloaded onto a smartphone have been found to be comparable to traditional paper versions in terms of their ability to measure pain. In addition to being portable and accessible, the digitization of pain assessments have the potential to reduce human errors that could occur during scoring and data recording. Furthermore, there is growing evidence that smartphone applications (apps) have the potential to improve compliance with disease and medication management by motivating patients to be involved in their own care. These properties make them promising tools for the management of postsurgical pain at home. The smartphone application "Panda" (Pain Assessment using a Novel Digital Application) developed by the British Columbia Children's Hospital (BCCH) Pediatric Anesthesia Research Team (PART), includes digital versions of the Faces Pain Scale - Revised (FPS-R) and Color Analog Scale (CAS), and has been validated in the pediatric population. Because the 100mm VAS and the 11-point NRS have been studied specifically in adults as tools for the evaluation of postoperative pain, the app will be modified to include these two scales to better suit this population.

4. Objectives:

Panda will be compared against the traditional versions for both the NRS-11 and 100mm VAS to analyse the following endpoints:

• Agreement between the two measures — the Panda score and the "traditional" score.

• Practicality: difference in failure rates in obtaining pain scores from Panda compared with the "traditional" methods

5. Research design:

This is an observational, randomized, cross-over controlled, open trial.

6. Statistical analysis:

• Practicality: Chi-squared tests will be used to assess the difference in failure rates in obtaining pain scores from Panda compared with the "traditional" methods

• Agreement: an interval approach described by Bland & Altman will be used to calculate the agreement between the the Panda scores and the 'traditional' scores.

Sample size: There will be 2 study groups- the 100mm VAS and NRS-11 groups. Each group will contain 2 subgroups - ages >18 to < 60 years and ≥60 to ≤ 75 years. The required sample of 32 patients per subgroup has been calculated on the basis of Liao's proposed sample size calculation for an agreement study based on the Bland-Altman interval method, setting the discordance rate (α) = 0.05 and the tolerance probability (β) = 80%. 160 patients will be recruited to allow for any unplanned gaps in data collection, patients withdrawing from the study and other exclusions

Recruitment information / eligibility

• Status: Completed
• Enrollment: 155
• Est. completion date: August 26, 2016
• Est. primary completion date: August 26, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 19 Years to 75 Years

Eligibility

Inclusion Criteria:

• Age 19 to 75

• ASA status I-III

• Undergoing a procedure with anticipated post-surgical pain

Exclusion Criteria:

• Undergoing eye surgery

• Significant cognitive impairment or neurological injury

• Psychomotor dysfunction

• Visual impairment

• Admission to the Intensive Care Unit.

Related Conditions & MeSH terms

• Pain, Postoperative
• Postoperative Pain

Intervention

Device:
• Panda

• Visual Analogue Scale - Original

Locations

Country	Name	City	State
Canada	Mount Saint Joseph Hospital	Vancouver	British Columbia
Canada	St. Paul's Hospital	Vancouver	British Columbia

Sponsors (3)

Lead Sponsor	Collaborator
University of British Columbia	British Columbia Children's Hospital, Providence Health & Services

Country where clinical trial is conducted

Canada, 

References & Publications (2)

Sun T, West N, Ansermino JM, Montgomery CJ, Myers D, Dunsmuir D, Lauder GR, von Baeyer CL. A smartphone version of the Faces Pain Scale-Revised and the Color Analog Scale for postoperative pain assessment in children. Paediatr Anaesth. 2015 Dec;25(12):1264-73. doi: 10.1111/pan.12790. — View Citation

Sunderland S, Yarnold CH, Head SJ, Osborn JA, Purssell A, Peel JK, Schwarz SK. Regional Versus General Anesthesia and the Incidence of Unplanned Health Care Resource Utilization for Postoperative Pain After Wrist Fracture Surgery: Results From a Retrospective Quality Improvement Project. Reg Anesth Pain Med. 2016 Jan-Feb;41(1):22-7. doi: 10.1097/AAP.0000000000000325. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Scale Agreement at Time Zero: Difference between two modes of administration of the visual analogue scale (VAS-100)	Comparison of two modes of administration of the VAS-100 (paper and smartphone). Investigators will report only the mean difference in pain intensity between the two scales.Both scales will be administered adjacently, the order will be randomly assigned.	Time zero took place in the postanesthesia care unit (PACU) within 15 minutes of emergence from general anesthesia or procedural sedation, after being deemed appropriate to assess by the bedside nurse
Primary	Scale Agreement at Time Zero: Difference between two modes of administration of the numeric rating scale (NRS-11)	Comparison of two modes of administration of the NRS-11 (paper and smartphone). Investigators will report only the mean difference in pain intensity between the two scales.Both scales will be administered adjacently, the order will be randomly assigned.	Time zero took place in the postanesthesia care unit (PACU) within 15 minutes of emergence from general anesthesia or procedural sedation, after being deemed appropriate to assess by the bedside nurse
Primary	Scale Agreement at Time One: Difference between two modes of administration of the visual analogue scale (VAS-100)	Comparison of two modes of administration of the VAS-100 (paper and smartphone). Investigators will report only the mean difference in pain intensity between the two scales.Both scales will be administered adjacently, the order will be randomly assigned.	Time One occurred when the patient met the postanesthesia care unit (PACU) discharge criteria as per institutional protocol, modified from PADSS (post anesthesia discharge scoring system), with minimum score 9/10. Up to 72 hours.
Primary	Scale Agreement at Time One: Difference between two modes of administration of the numeric rating scale (NRS-11)	Comparison of two modes of administration of the NRS-11 (paper and smartphone). Investigators will report only the mean difference in pain intensity between the two scales.Both scales will be administered adjacently, the order will be randomly assigned.	Time One occurred when the patient met the postanesthesia care unit (PACU) discharge criteria as per institutional protocol, modified from PADSS (post anesthesia discharge scoring system), with minimum score 9/10. Up to 72 hours.
Secondary	Preference of smartphone app or traditional visual analogue scale (VAS-100)	The participants were asked whether they preferred the Smartphone app, the original tool, or had no preference.	Before PACU discharge, the subjects were asked whether they preferred the Smartphone app, the original tool, or had no preference.
Secondary	Preference of smartphone app or traditional numeric rating scale (NRS-11)	The participants were asked whether they preferred the Smartphone app, the original tool, or had no preference.	Before PACU discharge, the subjects were asked whether they preferred the Smartphone app, the original tool, or had no preference.